Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,894,090 papers from all fields of science
Search
Sign In
Create Free Account
Prostate Cancer Prevention Trial
Known as:
PCPT
A phase III, randomized, placebo-controlled cancer prevention trial of >18,000 men coordinated by the Southwest Oncology Group. The trial will…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Transition of a Clinical Trial into Translational Research: The Prostate Cancer Prevention Trial Experience
P. Goodman
,
C. Tangen
,
+12 authors
S. Lippman
Cancer Prevention Research
2010
Corpus ID: 10616942
Large clinical trials provide a tremendous opportunity to integrate correlative, comprehensive biological studies with invaluable…
Expand
2010
2010
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.
Yuanyuan Liang
,
D. Ankerst
,
Michael A Sanchez
,
R. Leach
,
I. Thompson
Urology
2010
Corpus ID: 11150560
2008
2008
Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.
F. Schröder
,
C. Bangma
,
M. Roobol
European Urology
2008
Corpus ID: 5538435
2008
2008
Does the level of prostate cancer risk affect cancer prevention with finasteride?
I. Thompson
,
C. Tangen
,
H. Parnes
,
S. Lippman
,
C. Coltman
Urology
2008
Corpus ID: 205549215
Review
2007
Review
2007
High-grade prostate cancer in the Prostate Cancer Prevention Trial: fact or artifact?
G. Andriole
,
P. Humphrey
,
R. Serfling
,
R. Grubb
Journal of the National Cancer Institute
2007
Corpus ID: 36991482
JNCI | Editorials 1355 Chemoprevention of prostate cancer is a laudable and desirable goal. One strategy for chemoprevention is…
Expand
Review
2005
Review
2005
THE EFFECTS OF 5α-REDUCTASE INHIBITORS ON THE NATURAL HISTORY, DETECTION AND GRADING OF PROSTATE CANCER: CURRENT STATE OF KNOWLEDGE
G. Andriole
,
D. Bostwick
,
+4 authors
C. Roehrborn
2005
Corpus ID: 57231615
ABSTRACTPurpose: The Prostate Cancer Prevention Trial (PCPT) showed that the 5α-reductase inhibitor (5ARI) finasteride…
Expand
Review
2005
Review
2005
Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes.
Y. Lotan
,
J. Cadeddu
,
J. Lee
,
C. Roehrborn
,
S. Lippman
Journal of Clinical Oncology
2005
Corpus ID: 36031638
PURPOSE To assess the estimated effect of finasteride prevention of prostate cancer on overall survival. METHODS Data for our…
Expand
2005
2005
Estimated impact of the Prostate Cancer Prevention Trial on population mortality
J. Unger
,
I. Thompson
,
+4 authors
C. Coltman
Cancer
2005
Corpus ID: 21263113
The potential public health impact of the recently completed Prostate Cancer Prevention Trial (PCPT) is debated. The results…
Expand
Review
2004
Review
2004
The Prostate Cancer Prevention Trial: current status.
B. Higgins
,
I. Thompson
Journal of Urology
2004
Corpus ID: 37882335
PURPOSE The rationale, design considerations and current status of the Prostate Cancer Prevention Trial (PCPT) are presented…
Expand
2001
2001
Design considerations for efficient prostate cancer chemoprevention trials.
J.Jack Lee
,
Ron Lieberman
,
J. Sloan
,
S. Piantadosi
,
S. Lippman
Urology
2001
Corpus ID: 31618408
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE